1. Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing
- Author
-
Michelle Kristin Slawinski, May Ling Mah, N. Miller, Jamie L. Jackson, Kelly J. Lehman, Eric Camino, Jerry R. Mendell, M. Iammarino, Kan N Hor, Linda H. Cripe, and Samiah Al-Zaidy
- Subjects
Adult ,medicine.medical_specialty ,Population ,Cardiomyopathy ,Contrast Media ,Magnetic Resonance Imaging, Cine ,Gadolinium ,Disease ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,Cardiac magnetic resonance imaging ,Internal medicine ,Humans ,Medicine ,Prospective Studies ,030212 general & internal medicine ,Muscular dystrophy ,education ,Prospective cohort study ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,VO2 max ,Stroke Volume ,medicine.disease ,Magnetic Resonance Imaging ,Muscular Dystrophy, Duchenne ,Etiology ,Cardiology ,Cardiomyopathies ,Cardiology and Cardiovascular Medicine ,business - Abstract
Varied detection methods have resulted in conflicting reports on the prevalence of cardiac disease in Duchenne and Becker muscular dystrophy carriers (MDC).We performed a prospective cohort study of 77 genetically-confirmed MDC mothers, 22 non-carrier mothers, and 25 controls. All participants underwent Cardiopulmonary Exercise Testing (CPET) and Cardiac Magnetic Resonance imaging (CMR).25% of carriers had ventricular ectopy in recovery of exercise (RecVE) as compared to 1 non-carrier and no controls (p = .003). No difference in age or maximal oxygen consumption was noted. 11 carriers had abnormal (55%) left ventricular ejection fraction by CMR. Evidence of late gadolinium enhancement (LGE) was noted in 48% of MDC, 1 non-carrier patient and no control subjects (p .0001). Subset analysis of LGE+ and LGE- subjects revealed differences in age (44.1 v 38.6 yrs.; p = .005), presence of RecVE, (38.9% v 10.5%, p = .004), and high serum creatine kinase (CK) (289 U/l; 52.8% v 31.6%, p = .065).We describe the prevalence of disease using CPET and CMR in genetically-proven MDC. 49% of carriers had fibrosis, opposed to 5% of non-carriers, highlighting the importance of genetic testing in this population. Despite cardiomyopathy, functional assessment by treadmill was normal, illustrating the discrepancy in cardiac and skeletal muscle impacts. Age, RecVE and serum CK appear to have an important role in predicting cardiomyopathy. Serum CK levels suggest that a systemic higher global disease severity and not tissue heterogeneity may be the etiology for greater cardiac disease and relatively spared skeletal muscle disease in this population. Clinical Trial Registration https://clinicaltrials.gov/ct2/show/NCT02972580?term=mendellcond=Duchenne+Muscular+Dystrophyrank=5; ClinicalTrials.gov Identifier: NCT02972580.
- Published
- 2020
- Full Text
- View/download PDF